Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study-Reference-Cited by-同舟云学术

Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study

Published:2017-11-07 Issue:24 Volume:1 Page:2243-2246
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Eissa Hesham M.¹²,Lu Lu³,Baassiri Malek¹,Bhakta Nickhill¹³⁴,Ehrhardt Matthew J.¹³,Triplett Brandon M.⁵,Green Daniel M.³,Mulrooney Daniel A.¹³,Robison Leslie L.³,Hudson Melissa M.¹³,Ness Kirsten K.³

Affiliation:

1. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN;

2. Department of Pediatrics, University of Minnesota, Minneapolis, MN; and

3. Department of Epidemiology and Cancer Control,

4. Department of Global Pediatric Medicine, and

5. Department of Bone Marrow Transplant and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN

Abstract

Key Points Childhood HSCT survivors suffer from a higher burden of severe/life-threatening conditions compared to conventional therapy survivors. Seven percent of HSCT survivors exhibit frailty phenotype at early age, placing them at higher risk for early mortality.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/24/2243/878958/advances010280.pdf

Reference23 articles.

1. Pasquini MC , ZhuX. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides. https://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/Documents/2014_Summary_Slides.pptx. Accessed 15 January 2015.

2. Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy;Eapen;Biol Blood Marrow Transplant,2015

3. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation;Wingard;J Clin Oncol,2011

4. Clinical ascertainment of health outcomes among adults treated for childhood cancer;Hudson;JAMA,2013

5. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study;Hudson;Pediatr Blood Cancer,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study;Transplantation and Cellular Therapy;2024-01

2. Financial Hardship in Childhood Cancer Survivors Treated with Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study;Transplantation and Cellular Therapy;2023-11

3. Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland;International Journal of Cancer;2023-02-21

4. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation;Journal of Adolescent and Young Adult Oncology;2023-02-01

5. Severe, life‐threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood;Cancer;2022-12-09